title: Guidelines for diagnosis, prevention and treatment of hand eczema.
abstract: The guidelines aim to provide advice on the management of hand eczema (HE), using an evidence- and consensus-based approach. The guidelines consider a systematic Cochrane review on interventions for HE, which is based on a systematic search of the published literature (including hand-searching). In addition to the evidence- and consensus-based recommendation on the treatment of HE, the guidelines cover mainly consensus-based diagnostic aspects and preventive measures (primary and secondary prevention). Treatment recommendations include non-pharmacological interventions, topical, physical and systemic treatments. Topical corticosteroids are recommended as first line treatment in the management of HE, however continuous long-term treatment beyond six weeks only when necessary and under careful me-dical supervision. Alitretinoin is recommended as a second line treatment (relative to topical corticosteroids) for patients with severe chronic HE. Randomized control trials (RCT) are missing for other used systemic treatments and comparison of systemic drugs in “head-to-head” RCTs are needed.The guidelines development group is a working group of the European Society of Contact Dermatitis (ESCD) and has carefully tried to reconcile opposite views, define current optimal practice and provide specific recommendations, and meetings have been chaired by a professional moderator of the AWMF (Arbeitsgemeinschaft der Wis-senschaftlichen Medizinischen Fachgesellschaften; Association of the Scientific Medi-cal Societies in Germany).No financial support was given by any medical company. The guidelines are expected to be valid until December 2017 at the latest.
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Diepgen
authors.forename: Klaus E
authors.initials: KE
authors.lastname: Andersen
authors.forename: Oliver
authors.initials: O
authors.lastname: Chosidow
authors.forename: Peter Jan
authors.initials: PJ
authors.lastname: Coenraads
authors.forename: Peter
authors.initials: P
authors.lastname: Elsner
authors.forename: John
authors.initials: J
authors.lastname: English
authors.forename: Manigé
authors.initials: M
authors.lastname: Fartasch
authors.forename: Ana
authors.initials: A
authors.lastname: Gimenez-Arnau
authors.forename: Rosemary
authors.initials: R
authors.lastname: Nixon
authors.forename: Denis
authors.initials: D
authors.lastname: Sasseville
authors.forename: Tove
authors.initials: T
authors.lastname: Agner
mesh_terms: D006801:Humans; D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D003879:Dermatologic Agents / Q000008:administration & dosage; D003880:Dermatology / Q000592:standards; D004485:Eczema / Q000175:diagnosis / Q000628:therapy; D005060:Europe; D019317:Evidence-Based Medicine; D005858:Germany; D006229:Hand Dermatoses / Q000175:diagnosis / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D003879:Dermatologic Agents